GSK to get flu injection

DRUGS giant GlaxoSmithKline is gearing up to make almost &pound;1.3bn from sales of its swine flu drug treatments.<br /><br />In May the UK&rsquo;s largest drug firm said that it had already taken 128m orders for a vaccine, in deals worth approximately &pound;600m, including those from the UK. But with around 50,000 cases in the UK diagnosed last week and 429 deaths worldwide, analysts now forecast sales of a vaccine to reach at least &pound;1.3bn as concerns mount and mass immunisation is considered a possibility.<br /><br />GSK already has one of the leading antiviral treatments for swine flu in Relenza, but it has also ramped up production for a new vaccine and turned two of its treatment plants into H1N1 vaccine factories to ensure it is able to deliver batches by Autumn.<br /><br />CEO Andrew Witty will be quizzed on Wednesday at the interim results over sales forecasts for the vaccine.